Search research articles
Contact Us
Filters
Showing results (51-60 of 100) with videos related to
Page
of 10
Sort By:
International Journal of Cancer
|
December 29, 2005
Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus
Wayne A Phillips, Sarah E Russell, Marianne L Ciavarella, et al.
Cancer Research
|
November 3, 2004
Mutation of the PIK3CA gene in ovarian and breast cancer
Ian G Campbell, Sarah E Russell, David Y H Choong, et al.
Molecular Cancer
|
September 18, 2015
The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis
Helen B Pearson, Edwina McGlinn, Toby J Phesse, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
April 11, 2012
Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity
Charles H C Pilgrim, Laveniya Satgunaseelan, Alan Pham, et al.
Cancer Research
|
December 21, 2006
A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition
Briony E Cristiano, Joanna C Chan, Katherine M Hannan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 18, 2011
mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury
Charles H C Pilgrim, Kate Brettingham-Moore, Alan Pham, et al.
Nature
|
August 13, 2015
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
Alexandra Van Keymeulen, May Yin Lee, Marielle Ousset, et al.
The Biochemical Journal
|
December 11, 2013
Physiological expression of the PI3K-activating mutation Pik3ca(H1047R) combines with Apc loss to promote development of invasive intestinal adenocarcinomas in mice
Lauren M Hare, Toby J Phesse, Paul M Waring, et al.
Nature Communications
|
March 23, 2023
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, et al.
Oncotarget
|
May 14, 2016
Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution
Delphine Denoyer, Helen B Pearson, Sharnel A S Clatworthy, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 100) with videos related to
Sort By:
Page
of 10
International Journal of Cancer
|
December 29, 2005
Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus
Wayne A Phillips, Sarah E Russell, Marianne L Ciavarella, et al.
Cancer Research
|
November 3, 2004
Mutation of the PIK3CA gene in ovarian and breast cancer
Ian G Campbell, Sarah E Russell, David Y H Choong, et al.
Molecular Cancer
|
September 18, 2015
The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis
Helen B Pearson, Edwina McGlinn, Toby J Phesse, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
April 11, 2012
Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity
Charles H C Pilgrim, Laveniya Satgunaseelan, Alan Pham, et al.
Cancer Research
|
December 21, 2006
A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition
Briony E Cristiano, Joanna C Chan, Katherine M Hannan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 18, 2011
mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury
Charles H C Pilgrim, Kate Brettingham-Moore, Alan Pham, et al.
Nature
|
August 13, 2015
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
Alexandra Van Keymeulen, May Yin Lee, Marielle Ousset, et al.
The Biochemical Journal
|
December 11, 2013
Physiological expression of the PI3K-activating mutation Pik3ca(H1047R) combines with Apc loss to promote development of invasive intestinal adenocarcinomas in mice
Lauren M Hare, Toby J Phesse, Paul M Waring, et al.
Nature Communications
|
March 23, 2023
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, et al.
Oncotarget
|
May 14, 2016
Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution
Delphine Denoyer, Helen B Pearson, Sharnel A S Clatworthy, et al.
Page
of 10